Concordance of CSF Measures of Alzheimer's Pathology with Amyloid PET Status in a Preclinical Cohort: A Comparison of Lumipulse and Established Immunoassays

Ashvini Keshavan,Henrietta Wellington,Zhongbo Chen,Ayesha Khatun,Miles Chapman,Melanie Hart,David M. Cash,William Coath,Thomas D. Parker,Sarah M. Buchanan,Sarah E. Keuss,Matthew J. Harris,Heidi Murray-Smith,Amanda Heslegrave,Nick C. Fox,Henrik Zetterberg,Jonathan M. Schott

Alzheimer's & dementia Diagnosis, assessment & disease monitoring（2020）

引用 16|浏览43

暂无评分

摘要

We assessed the concordance of cerebrospinal fluid (CSF) amyloid beta (Aβ) and tau measured on the fully automated Lumipulse platform with pre‐symptomatic Alzheimer's disease (AD) pathology on amyloid positron emission tomography (PET).

查看译文

关键词

amyloid,CSF,Lumipulse,PET,tau

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要